A mind-bending hallucinogen is moving out of the counterculture and into the clinic. The Food and Drug Administration on ...
Prescription weight loss medications have become more popular in recent years, including medications like Ozempic and Wegovy. Medications that were created to treat diabetes or obesity are now being ...
In 2003, Wendy Dossett chaired an international symposium at a UK university. “I don’t remember chairing it. I know that I did, but I don’t remember anything that happened,” she says. At the time, she ...
Mental health and substance abuse disorders are the leading cause of disease burden — both financially and in terms of utilization — in the U.S., according to Kaiser Family Foundation. And compared ...
See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. A staggering 19 million U.S. children were estimated to be living in a ...
Farhadullah found himself on a path he never expected from a young age. While other kids his age were still in school, ...
expert reaction to an RCT for semaglutide in patients with alcohol use disorder and comorbid obesity
‘Once-weekly semaglutide versus placebo in patients with alcohol use disorder and comorbid obesity: a randomised, double-blind, placebo-controlled trial’ by Mette Kruse Klausen et al. was published in ...
Hosted on MSN
5 surprising opioid use disorder statistics
Opioid use disorder (OUD) is a serious and complex condition affecting millions of people across the country and contributing to a national public health emergency. Yet stigma and misinformation about ...
Newleos Announces Dosing of First Participant in Phase 1b Study of NTX-2001 for Alcohol Use Disorder
Newleos doses the first participant in a Phase 1b study of NTX-2001, a potential first-in-class TAAR1 partial agonist for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results